Roxatidine

Entity type image
Type: Keyphrase
Name: Roxatidine
First reported Apr 15 2013 - Updated Apr 15 2013 - 1 reports
Deutsche Bank AG
Deutsche Bank AG

SIHUAN PHARM (00460.HK) target raised to HK$4.8 -Deutsche

Deutsche Bank pointed out in a report that the profit growth of SIHUAN PHARM (00460.HK) in the coming 3-5 years will outperform over the industry average level. The newly launched Roxatidine enjoys a four-year patent exclusivity, and the sales turnover ... [Published Aastocks.com - Apr 15 2013]

More Content

All (2) | News (2) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
SIHUAN PHARM (00460.HK) target raised to HK$4.8... [Published Aastocks.com - Apr 15 2013]
Sihuan Pharma receives Chinese approval for gen... [Published PharmaBiz - Jan 18 2013]
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.